Home / News, Videos & Publications / News / Medical Research /

New USB-Like Disease Diagnostic Kits Provide Faster Results

New USB-Like Disease Diagnostic Kits Provide Faster Results

March 8, 2018

Medical Research, Robotics & High-Tech

Biosensorix founders Dr. Lukas Fajs and BGU Prof. Robert Marks

Israel21cBGN Technologies Ltd., BGU’s technology transfer company, in collaboration with Singapore-based Biosensorix, is developing next generation diagnostic kits that can provide medical professionals with more immediate results.

The new technology, in the form of a smart USB-like drive, is an electrochemical lateral flow immunosensor that conducts quantitative diagnosis to determine the severity of the disease or condition.

“There are fast-acting testing kits today that can be used both in the clinic and at home to diagnose a wide range of conditions and diseases, but none of them can discern the severity of the condition or disease,” says Prof. Robert Marks of BGU’s Avram and Stella Goldstein-Goren Department of Biotechnology Engineering.

Instead of waiting for lab results, medical staff will be able to receive immediate results and decide on a course of action.

Next generation, point-of-care diagnostic kit in the form of a smart USB-like drive

“One kit that was developed can detect dengue hemorrhagic fever, a disease endemic in Southeast Asia and South America. Most people with the disease are kept at the hospital until results come in,” says Prof. Marks. “The new kit allows the physician to release the patient within half an hour, saving time and money.”

A second application, still under development, assesses stroke severity and provides early detection of a secondary stroke, which can occur after release from the hospital. The new kit also has the potential to help distinguish ischemic stroke from stroke mimics, to determine its causes, its severity, and outcome, and help decide on correct treatment.

“With a stroke, every minute counts. A quick quantitative test means rapid diagnosis that is necessary for accurate timely treatment. This can save brain functions and even lives,” says Dr. Ora Horovitz of BGN Technologies Ltd.

Read more on the Israel21c website >>